Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
32
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
12
users have commented on this narrative
27
users have followed this narrative
13 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
AppFolio
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
AI-powered Workflow And Ecosystem Partnerships Will Modernize Property Management
Key Takeaways Rising AI adoption and digital transformation in property management strengthen AppFolio's customer acquisition, platform engagement, and long-term revenue prospects. Integrated ecosystem partnerships and investment in high-margin services increase platform stickiness, recurring revenue, and operational efficiency.
View narrative
US$337.50
FV
18.4% undervalued
intrinsic discount
17.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
4 days ago
author updated this narrative
Oncology Institute
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Florida And Nevada Expansions Will Strengthen Community Oncology Care
Key Takeaways Rapid expansion of value-based contracts and scaled risk-based care models is driving strong patient growth, margin expansion, and sustainable top-line gains. Market tailwinds, tech investments, and growing pharmacy operations position the company for durable demand, lower costs, and increased profitability.
View narrative
US$7.00
FV
45.9% undervalued
intrinsic discount
19.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
10 days ago
author updated this narrative
Balco Group
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Nordic And Maritime Expansion Will Ignite Sustainable Recovery
Key Takeaways Order growth, geographic expansion, and product portfolio diversification position Balco for future revenue gains and reduced regional concentration risk. Operational efficiency improvements and focus on sustainable, innovative solutions are expected to boost margins as renovation demand rises.
View narrative
SEK 32.00
FV
23.8% undervalued
intrinsic discount
6.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
Updated
narrative
BioGaia
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Expanding North American Demand Will Unlock New Health Trends
Key Takeaways Expansion in direct sales and mainstream retail channels supports sustained growth as preventative health trends and demand for natural, clinically-proven products intensify globally. Increased investment in innovation, marketing, and clinical research is expected to drive margin expansion and diversification despite short-term earnings pressure.
View narrative
SEK 130.00
FV
24.5% undervalued
intrinsic discount
11.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
Updated
narrative
908 Devices
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
US Federal And International Funding Will Expand Global Analysis Markets
Key Takeaways Expanding public and private sector funding, along with strong global demand, positions the company for accelerated growth and increased market share in molecular analysis devices. Operational improvements and a shift toward recurring revenue streams are expected to enhance margins, earnings stability, and reduce financial risk.
View narrative
US$10.00
FV
35.5% undervalued
intrinsic discount
5.76%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
10 days ago
author updated this narrative
Intellinetics
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Cloud And AI Trends Will Expand Digital Markets
Key Takeaways Investments in marketing, cloud solutions, and targeted verticals are set to drive recurring revenue growth, stronger margins, and greater market reach. Advanced AI integration and expanded partnerships position Intellinetics for enhanced product differentiation and scalable, predictable earnings.
View narrative
US$14.50
FV
37.3% undervalued
intrinsic discount
8.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
Updated
narrative
American Well
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Budget Cuts And Data Rules Will Cripple Healthcare Margins
Key Takeaways Heavy reliance on volatile government funding, intensifying competition, and stricter data regulations threaten margins, scalability, and long-term revenue stability. Ongoing cash burn and lacking profitability raise concerns about future equity dilution and the company's ability to sustain growth.
View narrative
US$7.50
FV
4.7% undervalued
intrinsic discount
-5.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
11 days ago
author updated this narrative
Motorcar Parts of America
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Rising Vehicle Longevity And Remanufacturing Will Expand Market Opportunities
Key Takeaways Growth in older vehicles and nondiscretionary repairs is supporting strong sales, cash flow, and expanding MPAA's market opportunities. New product expansion, operational efficiencies, and demand for remanufactured parts are expected to boost margins and secure long-term revenue stability.
View narrative
US$18.00
FV
19.7% undervalued
intrinsic discount
6.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Customers Bancorp
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Improved Digital Finance Will Drive Enduring Sector Leadership In 2028
Key Takeaways Differentiation through proprietary digital banking technology and targeted talent recruitment is fueling deposit, loan, and fee income growth while enhancing revenue quality and margins. Focus on underserved verticals, operational efficiency, and regulatory leadership is diversifying revenue streams and positioning the bank for sustainable, industry-leading earnings growth.
View narrative
US$76.57
FV
10.3% undervalued
intrinsic discount
17.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies